TLDR
- Cosmos Health expands into Kuwait with 65K Sky Premium Life unit order.
- Shares dip despite Kuwait expansion deal via Diyar United distribution.
- Kuwait deal secures exclusive Sky Premium Life entry into $1.16B market.
- Cosmos targets Gulf growth with wellness brand Sky Premium Life launch.
- Global expansion continues as Cosmos taps rising Middle East supplement demand.
Cosmos Health Inc. shares declined 2.70% during regular trading, closing at $1.08. The stock extended its losses in after-hours trading, dropping another 10.09% to $0.971. Despite the stock dip, the company reported a key international expansion deal through its Sky Premium Life brand.
Expansion into Kuwait Secured with 65,000 Unit Order
Cosmos Health’s subsidiary, SkyPharm S.A., signed an exclusive distribution agreement with Kuwait-based Diyar United. The agreement grants Diyar United full rights to register, market, and distribute Sky Premium Life® nutraceuticals in the Kuwaiti market. The deal includes a confirmed initial purchase of over 65,000 product units.
The portfolio includes vitamins, minerals, herbal blends, and supplements targeting skin, immunity, and overall wellness. Products such as collagen, hyaluronic acid, maca, turmeric, and multivitamin complexes form part of the launch. Additional purchase orders are anticipated, with the company expecting continued momentum in the region.
Diyar United brings decades of healthcare distribution expertise, including regulatory and logistics capabilities within Kuwait. Its established relationships and supply chain infrastructure align with Cosmos Health’s growth strategy. This move strengthens Cosmos’s presence in the Middle East and supports its global market penetration plans.
Kuwait’s Supplement Market Offers Strategic Opportunity
Kuwait’s nutritional supplements market reached $1.16 billion in 2024 and continues to expand steadily. Grand View Research projects the market to hit $1.68 billion by 2030, growing at a compound annual rate of 6.3%. This favorable outlook presents strong growth prospects for Cosmos Health’s wellness products.
Kuwaiti consumers are showing increasing interest in premium wellness and nutritional solutions. Sky Premium Life targets this demand with scientifically formulated and GMP-certified supplements. With Diyar United as a distribution partner, Cosmos Health expects accelerated product availability and brand visibility.
This agreement signals a firm commitment to entering new, high-growth regions with well-supported distribution partners. Cosmos Health aims to replicate similar market entries across other Gulf countries and beyond. Kuwait marks a strategic step in this broader global expansion roadmap.
Company Strengthens Portfolio Through Global Partnerships
Cosmos Health operates as a vertically integrated healthcare group with diverse operations across manufacturing, distribution, and R&D. It owns several brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, and C-Sept®. The company also produces pharmaceuticals and medical products through EU-certified facilities.
In addition to nutraceuticals, Cosmos engages in drug repurposing research using AI and has expanded into telehealth through its U.S. subsidiary, ZipDoctor. It supports healthcare needs with OTC medications, branded generics, and specialty products distributed in the EU and UK. Each move underlines its aim to position as a global healthcare innovator.
With this latest expansion, Cosmos Health accelerates its global growth mission. While short-term market fluctuations persist, the company remains focused on long-term strategic partnerships. Its direction emphasizes growth through science-driven products and market-specific alignment.
